188
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Influence of Red Blood Cell Distribution Width on All-Cause Death in Critical Diabetic Patients with Acute Kidney Injury

, , , ORCID Icon, , ORCID Icon & show all
Pages 2301-2309 | Published online: 02 Aug 2022

References

  • Tuttle KR, Bakris GL, Bilous RW, et al. Diabetic kidney disease: a report from an ADA consensus conference. Am J Kidney Dis. 2014;64:510–533. doi:10.1053/j.ajkd.2014.08.001
  • IDF. Diabetes Atlas. 10th. International Diabetes Federation; 2021.
  • Liborio AB, Leite TT, Neves FM, Teles F, Bezerra CT. AKI complications in critically ill patients: association with mortality rates and RRT. Clin J Am Soc Nephrol. 2015;10:21–28. doi:10.2215/CJN.04750514
  • Chen JJ, Kuo G, Hung CC, et al. Risk factors and prognosis assessment for acute kidney injury: the 2020 consensus of the Taiwan AKI task force. J Formos Med Assoc. 2021;120:1424–1433. doi:10.1016/j.jfma.2021.02.013
  • Kaddourah A, Basu RK, Bagshaw SM, Goldstein SL, Investigators A. Epidemiology of acute kidney injury in critically ill children and young adults. N Engl J Med. 2017;376:11–20. doi:10.1056/NEJMoa1611391
  • Advani A. Acute kidney injury: a bona fide complication of diabetes. Diabetes. 2020;69:2229–2237. doi:10.2337/db20-0604
  • Harding JL, Li Y, Burrows NR, Bullard KM, Pavkov ME. US trends in hospitalizations for dialysis-requiring acute kidney injury in people with versus without diabetes. Am J Kidney Dis. 2020;75:897–907. doi:10.1053/j.ajkd.2019.09.012
  • Go AS, Hsu CY, Yang J, et al. Acute kidney injury and risk of heart failure and atherosclerotic events. Clin J Am Soc Nephrol. 2018;13:833–841. doi:10.2215/CJN.12591117
  • Monseu M, Gand E, Saulnier PJ, et al. Acute kidney injury predicts major adverse outcomes in diabetes: synergic impact with low glomerular filtration rate and albuminuria. Diabetes Care. 2015;38:2333–2340. doi:10.2337/dc15-1222
  • Salvagno GL, Sanchis-Gomar F, Picanza A, Lippi G. Red blood cell distribution width: a simple parameter with multiple clinical applications. Crit Rev Clin Lab Sci. 2015;52:86–105. doi:10.3109/10408363.2014.992064
  • Aktas G, Alcelik A, Tekce BK, Tekelioglu V, Sit M, Savli H. Red cell distribution width and mean platelet volume in patients with irritable bowel syndrome. Prz Gastroenterol. 2014;9:160–163. doi:10.5114/pg.2014.43578
  • Rodríguez-Carrio J, Alperi-López M, López P, Alonso-Castro S, Ballina-García FJ, Suárez A. Red cell distribution width is associated with cardiovascular risk and disease parameters in rheumatoid arthritis. Rheumatology. 2015;54:641–646. doi:10.1093/rheumatology/keu345
  • Dagistan Y, Dagistan E, Gezici AR, et al. Could red cell distribution width and mean platelet volume be a predictor for lumbar disc hernias? Ideggyogy Sz. 2016;69:411–414. doi:10.18071/isz.69.0411
  • Aktas G, Sit M, Karagoz I, et al. Could red cell distribution width be a marker of thyroid cancer? J Coll Physicians Surg Pak. 2017;27:556–558.
  • Ustaoglu M, Aktas G, Avcioglu U, Bas B, Bahceci BK. Elevated platelet distribution width and red cell distribution width are associated with autoimmune liver diseases. Eur J Gastroenterol Hepatol. 2021;33:e905–e908. doi:10.1097/MEG.0000000000002296
  • Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120:c179–184. doi:10.1159/000339789
  • Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–553. doi:10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
  • Ujszaszi A, Molnar MZ, Czira ME, Novak M, Mucsi I. Renal function is independently associated with red cell distribution width in kidney transplant recipients: a potential new auxiliary parameter for the clinical evaluation of patients with chronic kidney disease. Br J Haematol. 2013;161:715–725. doi:10.1111/bjh.12315
  • Hu Y, Liu H, Fu S, Wan J, Li X. Red blood cell distribution width is an independent predictor of aki and mortality in patients in the coronary care unit. Kidney Blood Press Res. 2017;42:1193–1204. doi:10.1159/000485866
  • Nanjarapalle S, Samantaray A, Vishnubhotla S. Red cell distribution width as a severity marker on the outcome of patients with acute kidney injury on renal replacement therapy. Indian J Crit Care Med. 2020;24:95–98. doi:10.5005/jp-journals-10071-23342
  • Vashistha T, Streja E, Molnar MZ, et al. Red cell distribution width and mortality in hemodialysis patients. Am J Kidney Dis. 2016;68:110–121. doi:10.1053/j.ajkd.2015.11.020
  • Odutayo A, Wong CX, Farkouh M, et al. AKI and long-term risk for cardiovascular events and mortality. J Am Soc Nephrol. 2017;28:377–387. doi:10.1681/ASN.2016010105
  • Hsieh YP, Chang CC, Kor CT, Yang Y, Wen YK, Chiu PF. The predictive role of red cell distribution width in mortality among chronic kidney disease patients. PLoS One. 2016;11:e0162025. doi:10.1371/journal.pone.0162025
  • Jia L, Cui S, Yang J, et al. Red blood cell distribution width predicts long-term mortality in critically ill patients with acute kidney injury: a retrospective database study. Sci Rep. 2020;10:4563. doi:10.1038/s41598-020-61516-y
  • Kwak J, Kim JH, Jang HN, et al. Erythropoietin ameliorates ischemia/reperfusion-induced acute kidney injury via inflammasome suppression in mice. Int J Mol Sci. 2020;21:3453.
  • Forhecz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohaszka Z, Janoskuti L. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J. 2009;158:659–666. doi:10.1016/j.ahj.2009.07.024
  • Pavlakou P, Liakopoulos V, Eleftheriadis T, Mitsis M, Dounousi E. Oxidative stress and acute kidney injury in critical illness: pathophysiologic mechanisms-biomarkers-interventions, and future perspectives. Oxid Med Cell Longev. 2017;2017:6193694. doi:10.1155/2017/6193694
  • Aktas G, Sit M, Dikbas O, et al. Could red cell distribution width be a marker in Hashimoto’s thyroiditis? Exp Clin Endocrinol Diabetes. 2014;122:572–574. doi:10.1055/s-0034-1383564
  • Aktas G. Hematological predictors of novel coronavirus infection. Rev Assoc Med Bras. 2021;67(Suppl 1):1–2. doi:10.1590/1806-9282.67.suppl1.20200678
  • Cakir L, Aktas G, Enginyurt O, Cakir SA. Mean platelet volume increases in type 2 diabetes mellitus independent of HbA1c level. Acta Medica Mediterr. 2014;30:425–428.
  • Karagoz I, Aktas G, Yoldas H, et al. Association between hemogram parameters and survival of critically ill patients. J Intensive Care Med. 2019;34:511–513. doi:10.1177/0885066617703348
  • Bateman RMSharpe MD, Jagger JE, et al. 36th International symposium on intensive care and emergency medicine: Brussels, Belgium. 15–18 March 2016. Critical Care. 2016;20:94. doi:10.1186/s13054-016-1208-6
  • Cho AY, Yoon HJ, Lee KY, Sun IO. Clinical characteristics of sepsis-induced acute kidney injury in patients undergoing continuous renal replacement therapy. Ren Fail. 2018;40:403–409. doi:10.1080/0886022X.2018.1489288
  • Jeon H, Lee J, Ju JH, et al. Renal function deterioration is an independent mortality determinant in Koreans diagnosed with lupus nephritis. Lupus. 2021;30:1896–1905. doi:10.1177/09612033211038823
  • Mo M, Pan L, Huang Z, Liang Y, Liao Y, Xia N. Development and validation of a prediction model for survival in diabetic patients with acute kidney injury. Front Endocrinol. 2021;12:737996. doi:10.3389/fendo.2021.737996
  • Hoste EA, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41:1411–1423. doi:10.1007/s00134-015-3934-7
  • Di Lullo L, Reeves PB, Bellasi A, Ronco C. Cardiorenal syndrome in acute kidney injury. Semin Nephrol. 2019;39:31–40. doi:10.1016/j.semnephrol.2018.10.003
  • Kao CC, Yang WS, Fang JT, Liu KD, Wu VC. Remote organ failure in acute kidney injury. J Formos Med Assoc. 2019;118:859–866. doi:10.1016/j.jfma.2018.04.005
  • Rydzewska-Rosołowska A, Sroka N, Kakareko K, Rosołowski M, Zbroch E, Hryszko T. The links between microbiome and uremic toxins in acute kidney injury: beyond gut feeling-a systematic review. Toxins. 2020;12:788. doi:10.3390/toxins12120788
  • Udy AA, Roberts JA, Lipman J. Clinical implications of antibiotic pharmacokinetic principles in the critically ill. Intensive Care Med. 2013;39:2070–2082. doi:10.1007/s00134-013-3088-4
  • De Waele JJ, Lipman J, Akova M, et al. Risk factors for target non-attainment during empirical treatment with beta-lactam antibiotics in critically ill patients. Intensive Care Med. 2014;40:1340–1351. doi:10.1007/s00134-014-3403-8